Magdent: Clinical and Market Updates

by Benny Barak

Magdent has made remarkable progress over the past few months, solidifying its leadership and innovation in dental technology. Key achievements include significant FDA advancements, a notable increase in sales, and the publication of groundbreaking clinical studies on peri-implantitis treatment.

FDA Advancements

Magdent has embarked on the journey to obtain FDA clearance, beginning with a pre-clinical study this quarter to demonstrate the efficacy and safety of their MED technology, based on the 3rd Presub. They are also conducting biocompatibility and engineering tests under the 510K DeNovo, with completion expected in Q1 2025.

Following the pre-clinical study’s completion in Q2 2025, Magdent will commence a clinical study based on a pre-approved protocol (from the 4th Presub) for peri-implantitis treatment. This protocol is supported by their successful clinical study at Rambam Hospital, which showed that PEMF technology promotes bone growth in inflammatory conditions, increases bone levels, and reduces infection indicators.

Sales Growth

Recent sales data indicate a significant uptick for Magdent, driven by the increasing adoption of their MED technology by dental professionals and implant companies. This growth reflects the trust the dental community places in Magdent's solutions.

Their strategic marketing efforts—direct communication with implant companies instead of exclusive local distributors, and a strong presence at dental events—have contributed to this impressive sales momentum.

Clinical Studies and Innovation

Magdent continues to achieve great results in their ongoing studies. These focus not only on treating peri-implantitis, with an upcoming publication on its long-term effects, but also on preventing peri-implant disease. Additionally, they have initiated a pre-clinical study in Brazil to evaluate PEMF's effect on bone grafting.

Success in this study could open a vast market opportunity for Magdent, incorporating PEMF into the regenerative field and offering innovative solutions for patients needing bone grafting with implants. In the coming weeks, they will publish three more studies in prominent dental journals, showcasing their commitment to scientific rigor and innovation, and present their technology in the Dental Tribune. These findings demonstrate that their technology not only improves treatment outcomes but also enhances patient satisfaction and quality of life.

Global Recognition and Collaboration

The publication of these studies has attracted significant attention from the global dental community, positioning Magdent as a thought leader. They continue to collaborate with leading dental researchers and institutions to validate their technology and explore new applications.

Investment Opportunities

Check out Magdent on Catapult Crown to share in their success.